Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

Alexander G. Thompson, Elizabeth Gray, Nick S. Verber, Yoana Bobeva, Vittoria Lombardi, Stephanie R. Shepheard, Özlem Yildiz, Emily Feneberg, Lucy E Farrimond, Thanuja Dharmadasa, Pamela Gray, Evan Edmond, Jakub Scaber, Delia Gagliardi, Janine Kirby, Thomas Michael Jenkins, Pietro Fratta, Christopher J. McDermott, Sanjay Manohar, Kevin Talbot, Andrea Malaspina, Pamela J. Shaw, Martin R. Turner
ISSN / E-ISSN
— / —
DOI
10.1093/braincomms/fcac029 ↗
Volume · Issue · Pages
4 · 1 · fcac029-fcac029
Publisher
Oxford University Press
Article URL
https://doi.org/10.1093/braincomms/fcac029 ↗
Article details
Unverified
Publication date (each date has its type and source)
04 Jan 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date04 Jan 2022 OpenAlex

Keywords (as given): amyotrophic lateral sclerosis; neurofilament light chain; blood biomarkers; cerebrospinal fluid biomarkers; creatine kinase; ferritin; complement C3; C4; C-reactive protein; disease activity monitoring; disability progression; survival; ALSFRS-R; neurodegeneration

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for hjrs 2021-22 V2.
Journal
Brain Communications
Publication date used
04 Jan 2022 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
Y
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2021-22 row 44318
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.